JUN 05, 2018 9:45 PM PDT

Precision vs. Personalized Medicine Part I: Precision Approach

WRITTEN BY: Mauri Brueggeman

Are you hearing a lot about personalized medicine these days?  What about precision medicine? It seems like the information being discussed is not necessarily new.  Why does it seem to be everywhere lately?  There are many answers to that but this two part series aims to outline some of the features of these models of medicine as a foundation.

Precision medicine is defined as a model for medicine that is customized based on the individual patient; all aspects of care can be personalized including medical decisions, treatments, practices, and products or services used.  Another similar sounding term is “personalized medicine”.  That National Institutes of Health indicates that there is overlap in the two terms.  The real difference is mostly in the interpretation of the word “personalized” as compared to “precision”. 

Precision, as a single word, means to hit a target in the same place over and over.  Precision medicine aims to create medicine models that target a similar feature of a disease that appears in multiple diseases or cancers in some cases.  This model is not unique for one single individual, however.  This approach aims to identify which approaches will be effective for patients based on genetic, environmental, and lifestyle aspects. 

The changes in technology and knowledge acquisition over the past few decades allow clinicians and researchers access to heaps of data on different cancer types.  The historical approach has been to lump the cancer types together and treat everyone with that cancer type in the same therapeutic manner.  Yet there are patients that do not respond to that therapy at all despite having the pathology/morphology of one type of cancer.  We now know that there are molecular factors at play, right down to our DNA, which affect how a treatment may work on those cancerous cells.  If the treatment action is based on one pathway leading to disease, what happens when that disease occurs due to a different pathway malfunction?  Precision medicine dumps into the field of computational oncology which employs the expertise of statisticians, mathematicians, physicists, computer scientists, cancer biologists, physiological experts, physicians, researchers, and many more to create data programs and models including genetic profiles and therapeutic approaches for different cancers.  In addition, pharmacogenetics is part of precision medicine because the whole basis of this field of study is how gene’s affect a particular patient’s response to a given pharmaceutical agent.  If you enjoy pharmacology and genomics, this is the field for you.

The National Research Council has documented that they prefer the term precision medicine; the work involves building a network for biomedical research in order to basically develop a new taxonomical structure for disease.  The National Academy of Sciences, in collaboration with the National Academy of Engineering, the Institute of Medicine, and the National Research Council, published a report exploring the future of precision medicine in 2011. 

Sources: NIH – U.S. National Library of Medicine, National Academies Press – National Research Council,  Journal for Biomedical Informatics, Annals of Gastroenterology & Surgery,

 

 

About the Author
Master's (MA/MS/Other)
Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JAN 03, 2023
Cell & Molecular Biology
From sample collection straight to RT-qPCR
From sample collection straight to RT-qPCR
Skip the nucleic acid purification step in your cancer detection workflow. Learn more about how Thermo Fisher Scientific ...
NOV 02, 2022
Clinical & Molecular DX
New Genetic Variants Identified as Risk Factors for Ovarian Cancer
New Genetic Variants Identified as Risk Factors for Ovarian Cancer
Ovarian cancer is a complex disease resulting from mutated cells in the ovaries. As the cells multiply, they can invade ...
NOV 21, 2022
Cancer
More People Living with Metastatic Cancer
More People Living with Metastatic Cancer
Experts define metastatic cancer as cancer that spreads from the anatomical location where it started to a distant part ...
DEC 14, 2022
Genetics & Genomics
Labroots' Top 10 Scientific Discoveries of 2022
Labroots' Top 10 Scientific Discoveries of 2022
2022 was a big year for science, so let’s take a look at some of the most interesting -and important- scientific d ...
JAN 04, 2023
Clinical & Molecular DX
Dual-Action Cancer Vaccine Targets Brain Tumors Directly
Dual-Action Cancer Vaccine Targets Brain Tumors Directly
Scientists have developed a new, targeted strategy to eliminate brain tumors and prevent future recurrences of brain can ...
JAN 10, 2023
Health & Medicine
Liver Let Die: Dying Liver Cells Disclose Cancer Diagnosis
Liver Let Die: Dying Liver Cells Disclose Cancer Diagnosis
The methylation patterns of DNA in the blood offer insight into the liver disease stage
Loading Comments...